Skip to content

Solitary kidney, tumors in both kidneys or chronic kidney disease

What changes in partial nephrectomy when the remaining kidney has to last, in a solitary kidney, with tumors in both kidneys and in chronic kidney disease.

Dr. Petronio Melo, urologistA reference in robotic surgery for kidney and bladder tumors
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 15, 2026
Book a consultation
Front-view drawing of a single kidney with a small tumor, and the empty place of the other kidney, marked only by a dashed outline
On this page

Quick answer

When a tumor appears in a solitary kidney, in both kidneys or in someone who already has chronic kidney disease, the kidney that remains has to last. That gives even more weight to partial nephrectomy, which removes the tumor and preserves the rest of the kidney. The European guideline says that, in these cases, it should be considered even for tumors larger than 7 cm, if technically feasible.1 In a series of 841 people with a solitary kidney treated with partial nephrectomy, 97% were dialysis-free 5 years later.7 Surgery, surveillance and ablation are weighed case by case.

Why every piece of kidney counts more

With two normal kidneys, the other kidney makes up for what is lost in surgery. With only one kidney, or with kidney function already reduced, that reserve is not there.

A solitary kidney can be present from birth or remain after the other one was removed. In a series of 400 people with a tumor in a solitary kidney, 81% had lost the other kidney to surgery and 19% were born with only one.6

Surgeons divide the indications for partial nephrectomy into imperative, relative and elective.5 The European guideline calls surgery in a solitary kidney and in tumors in both kidneys imperative.1 Some studies place chronic kidney disease in the same group.14

For tumors up to 7 cm, partial nephrectomy is already the treatment of choice for everyone.1 For larger ones, the guideline says it should be considered in people with a solitary kidney, tumors in both kidneys or chronic kidney disease, if it is technically feasible and enough tissue remains for the kidney to work afterward.1 The two operations are compared in Partial or radical nephrectomy.

Kidney function and the risk of dialysis

Kidney function is measured as filtration, in mL/min/1.73 m². Below 60 already counts as moderate chronic kidney disease. After a partial nephrectomy in a solitary kidney, filtration usually drops a little, because part of the tissue comes out with the tumor and the kidney goes without blood for a while.7

SeriesWhat it showed
400 people, open surgery46% already had reduced kidney function before surgery. Only 2 needed permanent dialysis right after surgery, and 95.5% kept satisfactory function in the long term. Another 18 progressed to kidney failure, on average 3.6 years later6
841 peopleMedian filtration of 56.7 before, 43.1 after recovery and 44.5 at 5 years. At 5 years, 97% were dialysis-free7
74 people, robotic surgeryMedian drop of 7.0 in filtration at 3 months, about 11%. Complications in 24.1% and a positive margin in 5.4%8

In the series of 841 people, the amount of kidney preserved explained 69% of the drop in filtration. Clamping and the other factors accounted for 3 to 4 points.7 In a series of 660 solitary kidneys, the amount of tissue preserved and function before surgery were also what mattered most for final function.12

In the series of 400 people, surgical complications occurred in 13%, most often urine leaking from the suture site.6 A positive margin, when tumor cells are found at the edge of the specimen, is more frequent when surgery is imperative, in a solitary kidney and in tumors in both kidneys.1 The risks in general are covered in partial nephrectomy complications.

How long the artery is clamped

To remove the tumor in a clear field, the surgeon usually clamps the kidney artery for a few minutes. During that time, called warm ischemia, the kidney goes without blood. In the CLOCK trial, in people with two kidneys and normal function, operating with or without clamping gave similar function at 6 months.1

In a study of 362 people with a solitary kidney operated on with clamping, by open or laparoscopic surgery, the median clamping time was 21 minutes. Each extra minute raised the risk of acute kidney failure after surgery, and 25 minutes was the cutoff that best separated those who did and did not have kidney problems, both early and in the long term.10 In another study by the same group, acute kidney failure was more common with clamping than without it. But the people operated on without clamping had smaller tumors, and the choice of technique was left to the surgeon.11

Clamping time is not the only factor. In the series of 660 solitary kidneys, once the amount of tissue preserved was taken into account, clamping time no longer affected final function.12 In the series of 841 people, clamping was the only factor linked to acute kidney injury right after surgery, but the amount of kidney preserved explained most of the long-term drop.7

The European guideline notes that the CLOCK trial only included people with two kidneys, and that operating without clamping may still have a place in a solitary kidney, chronic kidney disease or multiple tumors.1 In my practice, I clamp the artery almost always and leave it unclamped only in very favorable cases. In each case, we look together at the size and position of the tumor and at kidney function before deciding.

The robotic approach in a solitary kidney

A 2026 review compared robotic and open surgery in 333 people with a solitary kidney, across 4 studies. Kidney function at 12 months, the need for temporary dialysis and worsening of chronic kidney disease were similar. The robotic approach had shorter clamping, less bleeding and earlier discharge.9 The studies are small and retrospective, and the authors call for better studies before drawing a conclusion.9

In an international series of 74 people with a solitary kidney operated on with the robot, only one needed the whole kidney removed, and the median clamping time was 15.5 minutes.8

Tumors in both kidneys

When there are tumors in both kidneys, preservation applies to both sides. In a study of 94 people with solid tumors in both kidneys, without von Hippel-Lindau syndrome, 70% were treated in a single operation and 30% in stages.13 Recurrence at the same site was uncommon: 96% were free of it at 5 years.13 The order of the operations and the interval between them are decided case by case.

Tumors in both kidneys also raise the possibility of a hereditary form. The European guideline recommends a genetic evaluation for people with tumors in both kidneys or in several spots, for people aged 46 or younger and for those with close relatives with kidney cancer.2 In hereditary forms, tumors are often multiple, come back and appear in both kidneys, and the guideline recommends preserving the kidney in most of them, because of the risk of chronic kidney disease.4 In von Hippel-Lindau syndrome, the recommendation is to monitor until the largest tumor reaches 3 cm, to reduce the number of operations.4

Chronic kidney disease and the nephrologist

Chronic kidney disease is the slow loss of kidney function. In people who already have it, the European guideline considers partial nephrectomy the treatment of choice, to lower the risk of reaching kidney failure, which requires hemodialysis.1

Before surgery, the guideline recommends measuring how much each kidney works, with a renal scan (scintigraphy), when kidney function is reduced and when it is especially important, as in a solitary kidney or with multiple tumors or tumors in both kidneys.2

After treatment, the guideline suggests referring people at risk of losing function to a nephrologist, the kidney specialist, such as those left with a filtration of 45 or less. This follow-up helps protect the remaining kidney and choose how to do the follow-up scans, for example whether and when to use CT contrast.3

Surveillance and ablation

Not every tumor needs surgery right away. The European guideline recommends active surveillance, with regular scans, for tumors up to 4 cm with no need for immediate treatment, when a later intervention would be appropriate.1 Ablation destroys the tumor with heat or cold, usually through a needle placed through the skin. The guideline recommends it, as well as stereotactic radiotherapy, for T1 tumors that need treatment in people who cannot have surgery.1 It does not routinely recommend radiofrequency for tumors larger than 3 cm or cryoablation for tumors larger than 4 cm.1

In a study of 284 people with an imperative indication, because of a solitary kidney, tumors in both kidneys or chronic kidney disease, ablation had fewer complications, fewer transfusions and a shorter hospital stay. Partial nephrectomy treated larger and more complex tumors and gave better local control. Loss of function and the need for dialysis were similar.14 In a review of 7 studies in solitary kidneys only, cryoablation preserved function better, with no significant difference in local recurrence or metastases.15

In the consultation, I compare surgery, ablation and surveillance with you, with the advantages and limits of each. If the tumor is small, the page on small kidney masses explains these options in more detail.

How I approach it

I have performed robotic partial nephrectomy since 2020, through a transperitoneal approach, and I operate with the da Vinci X and da Vinci Xi platforms, depending on hospital availability. In total, I have done more than 1,500 robotic and laparoscopic surgeries, more than 500 of them robotic. With a solitary kidney, tumors in both kidneys or chronic kidney disease, I go over the scans, the position of the tumor and kidney function with you, and compare surgery with the other options. In my practice, the hospital stay is under 24 hours, the catheter is removed before discharge and most cases do not need a drain. The decision is made together with you, and your family can take part if you wish. If you live outside Brazil, the first consultation can be online, in English, with your tests sent in advance. When needed, I refer you to a nephrologist.

When to see a urologist

  • If you have only one kidney and a scan showed a mass in it
  • If a scan showed tumors in both kidneys
  • If you already have chronic kidney disease and were told to have the kidney removed
  • If you want a second opinion before surgery
  • After surgery, if you pass much less urine or the urine has blood in it

Send your case

If you have a kidney tumor and would like my opinion on your case before a consultation, fill in the form below and, if you can, attach your CT or MRI report. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

I have only one kidney and a tumor in it. Can it be treated without removing the kidney?

Often, yes. The European guideline recommends partial nephrectomy for tumors up to 7 cm and says that, in people with a solitary kidney, tumors in both kidneys or chronic kidney disease, it should be considered even for larger tumors, if technically feasible.1 The size and position of the tumor, seen on the scans, tell whether it is possible.

Will I need dialysis after surgery?

Most of the time, no. In a series of 841 people with a solitary kidney treated with partial nephrectomy, 97% were dialysis-free 5 years later.7 In another, with 400 people, only 2 needed permanent dialysis right after surgery.6

Does the kidney lose function after a partial nephrectomy?

Some. In a series of 841 people with a solitary kidney, median filtration fell from 56.7 to 43.1 after recovery and stayed stable, at 44.5, at 5 years. The amount of kidney preserved explained most of that drop.7

Does clamping time matter in a solitary kidney?

Yes. In a study of 362 people with a solitary kidney, each extra minute of clamping raised the risk of acute kidney failure after surgery.10 In the long run, how much kidney tissue is left matters more than clamping time.12 In my practice, I clamp the artery almost always, and the decision is made case by case.

Is robotic surgery an option for a solitary kidney?

In a 2026 review of 333 people with a solitary kidney, robotic and open surgery had similar kidney function at 12 months. The robotic approach had shorter clamping, less bleeding and earlier discharge. The studies are small and retrospective.9

What if I have tumors in both kidneys?

In a study of 94 people with tumors in both kidneys, 70% were treated in a single operation and 30% in stages, preserving the kidneys.13 The European guideline also recommends a genetic evaluation for people with tumors in both kidneys.2

Are there options other than surgery?

Yes. The European guideline recommends active surveillance for some tumors up to 4 cm, and ablation or stereotactic radiotherapy for people who need treatment but cannot have surgery.1 In a solitary kidney, one review found better preservation of function with cryoablation, with no significant difference in local recurrence.15 We go over these options together in the consultation.

Who performs robotic partial nephrectomy on a solitary kidney in São Paulo?

I am Dr. Petronio Melo, a urologist and robotic surgeon in São Paulo, CRM-SP 157.598 and RQE 70.275. I have performed robotic partial nephrectomy since 2020, through a transperitoneal approach, and I operate with the da Vinci X and da Vinci Xi platforms, depending on hospital availability. In total, I have done more than 1,500 robotic and laparoscopic surgeries, more than 500 of them robotic. With a solitary kidney, tumors in both kidneys or chronic kidney disease, I compare surgery, surveillance and ablation with each patient. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. EAU Guidelines on Renal Cell Carcinoma. European Association of Urology; 2026. Disease management chapter. EAU
  2. EAU Guidelines on Renal Cell Carcinoma. European Association of Urology; 2026. Diagnostic evaluation chapter. EAU
  3. EAU Guidelines on Renal Cell Carcinoma. European Association of Urology; 2026. Follow-up chapter. EAU
  4. EAU Guidelines on Renal Cell Carcinoma. European Association of Urology; 2026. Hereditary and syndrome-specific RCC chapter. EAU
  5. Joniau S, Vander Eeckt K, Van Poppel H. The indications for partial nephrectomy in the treatment of renal cell carcinoma. Nat Clin Pract Urol. 2006;3(4):198-205. PubMed
  6. Fergany AF, Saad IR, Woo L, Novick AC. Open partial nephrectomy for tumor in a solitary kidney: experience with 400 cases. J Urol. 2006;175(5):1630-3. PubMed
  7. Attawettayanon W, Yasuda Y, Zhang JH, et al. Functional recovery after partial nephrectomy in a solitary kidney. Urol Oncol. 2024;42(2):32.e17-32.e27. PubMed
  8. Arora S, Abaza R, Adshead JM, et al. 'Trifecta' outcomes of robot-assisted partial nephrectomy in solitary kidney: a Vattikuti Collective Quality Initiative (VCQI) database analysis. BJU Int. 2018;121(1):119-123. PubMed
  9. Cao S, Qin J, Zhang Q, et al. Robot-assisted versus open partial nephrectomy in patients with a solitary kidney: a systematic review and meta-analysis of perioperative and functional outcomes. J Robot Surg. 2026;20(1):1142. PubMed
  10. Thompson RH, Lane BR, Lohse CM, et al. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol. 2010;58(3):340-5. PubMed
  11. Thompson RH, Lane BR, Lohse CM, et al. Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol. 2010;58(3):331-6. PubMed
  12. Lane BR, Russo P, Uzzo RG, et al. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol. 2011;185(2):421-7. PubMed
  13. Blute ML, Amling CL, Bryant SC, Zincke H. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease. Mayo Clin Proc. 2000;75(10):1020-6. PubMed
  14. Long JA, Bernhard JC, Bigot P, et al. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting. World J Urol. 2017;35(4):649-656. PubMed
  15. Liu Y, Wang L, Bao EH, et al. Perioperative, functional, and oncological outcomes after cryoablation or partial nephrectomy for small renal masses in solitary kidneys: a systematic review and meta-analysis. BMC Urol. 2024;24(1):19. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides